GGrantIndex
← Search

NOVEL CB1 RECEPTOR ANTAGONIST: PHASE II-271077424

$0N44FY2006DANIH

Makscientific. Llc

Investigators

Jerzy Golikcontact
View original record on NIH RePORTER →